Ocrelizumab treatment in patients with rrms who had a suboptimal response with one or more prior disease-modifying therapies: chords 2-year results

被引：0

作者：

Weinstock-Guttman, B. ^{[1
]}

Bermel, R. ^{[2
]}

Cutter, G. ^{[3
]}

Freedman, M. ^{[4
]}

Leist, T. ^{[5
]}

Pei, J. ^{[6
]}

Kile, D. ^{[6
]}

Musch, B. ^{[6
]}

Reder, A. ^{[7
]}

Wolinsky, J. ^{[8
]}

机构：

[1] SUNY Buffalo, Buffalo, NY USA

[2] Cleveland Clin, Cleveland, OH 44106 USA

[3] Univ Alabama Birmingham, Birmingham, AL USA

[4] Ottawa Hosp, Res Inst, Ottawa, ON, Canada

[5] Thomas Jefferson Univ, Philadelphia, PA 19107 USA

[6] Genentech Inc, San Francisco, CA 94080 USA

[7] Univ Chicago, Chicago, IL 60637 USA

[8] Univ Texas Hlth Sci Ctr Houston UTHlth, Houston, TX USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P0221

引用

页码：225 / 226

页数：2